TREA

79265470 - PB PB LEINER

Follow

Information

  • Trademark
  • 79265470
  • Serial Number
    79265470
  • Registration Number
    6132463
  • Filing Date
    June 17, 2019
    5 years ago
  • Registration Date
    August 25, 2020
    4 years ago
  • Transaction Date
    January 10, 2021
    3 years ago
  • Status Date
    August 25, 2020
    4 years ago
  • Published for Opposition Date
    June 09, 2020
    4 years ago
  • Location Date
    May 05, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    CARR, PATRICK C
  • Attorney Name
    Bradley M. Stohry
    Law Office Assigned Location Code
    N70
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
PB PB LEINER
Case File Statements
  • CC0000: The color(s) blue and green is/are claimed as a feature of the mark.
  • DM0000: The mark consists of the stylized wording "PB LEINER" underneath a design of the letters "PB" formed by triangles. The "B" in the design and the wording "LEINER are in blue and the "P" in the design and the wording "PB" are in green. The color white represents background, outlining, shading, and/or transparent area is not part of the mark.
  • GS0011: Protein in raw material form for industrial manufacturing purposes; protein in raw material form for scientific and medical purposes; proteins for industrial purposes; proteins for use in manufacture; proteins for use in the manufacture of food supplements; proteins for the food industry; proteins for use in the manufacture of cosmetics; collagen for industrial purposes; gelatin for industrial purposes; chemical preparations for stimulating cooking for industrial purposes, namely, chemical foaming agents, thickening agents, stabilizing agents, gelling agents, binding agents, emulsifying agents; protein as a raw material for the food industry; protein for use in the manufacture of foodstuffs; proteins for use in the manufacture of food products; protein as a raw material for manufacturing food for human consumption; proteins for use in the manufacture of beverages; proteins for use in the manufacture of food stuffs, namely, proteins which form gels as part of the manufacturing process of human food stuffs; proteins for use in the manufacture of food stuffs, namely, proteins for human foodstuffs which form emulsions as part of the manufacturing process; collagen used as a raw ingredient in the manufacture of cosmetics; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; proteins for use in the manufacture of capsules for pharmaceuticals; proteins for use in the manufacture of pharmaceuticals, namely, proteins for encapsulation and microencapsulation of pharmaceuticals; proteins for use in the manufacture of food for animal consumption; proteins for use in the manufacture of veterinary products; collagen for industrial purposes; collagen for use in the manufacture of pharmaceuticals; collagen for use in the manufacture of foodstuffs; collagen for use in the manufacture of beverages; collagen for use in the manufacture of food supplements; collagen for use in the manufacture of veterinary products; collagen for use in the manufacture of food for animal consumption; collagen for use in the manufacture of capsules for pharmaceuticals; collagen for use in the manufacture of pharmaceuticals, namely, collagen for encapsulation and microencapsulation of pharmaceuticals; non-nutritive mixture of protein in the nature of collagen for use as an ingredient in the manufacture of food, namely, for forming an edible, external layer on food products during the co-extrusion processing of foodstuffs; collagen peptides as a raw material for industrial purposes; collagen peptides for industrial purposes; collagen peptides for use in the manufacture of foodstuffs; collagen peptides for use in the manufacture of beverages; collagen peptides for use in the manufacture of food supplements; collagen peptides used as a raw ingredient in the manufacture of cosmetics; collagen peptides for use in the manufacture of veterinary products; collagen peptides for use in the manufacture of food for animal consumption; collagen peptides for use in the manufacture of capsules for pharmaceuticals; collagen peptides for use in the manufacture of pharmaceuticals, namely, collagen for encapsulation and microencapsulation of pharmaceuticals; collagen peptides for use in the manufacture of coatings for pharmaceutical preparations
Case File Event Statements
  • 1/10/2021 - 3 years ago
    37 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 12/17/2020 - 3 years ago
    36 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 12/16/2020 - 3 years ago
    35 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 12/2/2020 - 3 years ago
    34 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 12/2/2020 - 3 years ago
    33 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 12/2/2020 - 3 years ago
    32 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 12/2/2020 - 3 years ago
    31 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 12/2/2020 - 3 years ago
    30 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 11/25/2020 - 3 years ago
    29 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 8/25/2020 - 4 years ago
    28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/13/2020 - 4 years ago
    27 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 6/9/2020 - 4 years ago
    26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/9/2020 - 4 years ago
    25 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/5/2020 - 4 years ago
    24 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 5/20/2020 - 4 years ago
    23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 5/20/2020 - 4 years ago
    22 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 5/20/2020 - 4 years ago
    21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/5/2020 - 4 years ago
    20 - LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN Type: LOPR
  • 5/1/2020 - 4 years ago
    19 - LETTER OF PROTEST EVIDENCE FORWARDED Type: LOPT
  • 3/30/2020 - 4 years ago
    18 - ASSIGNED TO LIE Type: ALIE
  • 3/24/2020 - 4 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/20/2020 - 4 years ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 3/20/2020 - 4 years ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 3/20/2020 - 4 years ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 3/20/2020 - 4 years ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/10/2020 - 4 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/9/2020 - 4 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/9/2020 - 4 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/19/2019 - 5 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 10/1/2019 - 5 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 10/1/2019 - 5 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 9/25/2019 - 5 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 9/24/2019 - 5 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/7/2019 - 5 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/3/2019 - 5 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 8/30/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 8/15/2019 - 5 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR